March 05, 2015 7:49 PM ET

Healthcare Equipment and Supplies

Company Overview of ConvaTec Healthcare B S.a.r.l.

Company Overview

ConvaTec Healthcare B S.a.r.l. develops, manufactures, and markets medical technologies worldwide. It offers ostomy care products, including one- and two-piece ostomy systems, as well as accessories, such as pastes, powders, strips, seals, adhesive removers, and a special line of clothing; and wound dressings, including antimicrobial and foam dressings, and skin care products. The company also provides continence and critical care products comprising systems for managing acute fecal incontinence, monitoring urine production output, and monitoring intra-abdominal pressure; and disposable medical devices for use in high-volume procedures in urology, intensive care, operating rooms, and other h...

7 A Rue Robert Stumper

Luxembourg,  2557

Luxembourg

Founded in 2008

8,000 Employees

Key Executives for ConvaTec Healthcare B S.a.r.l.

Chief Executive Officer and Director
Age: 51
Chief Financial Officer
Age: 40
Senior Vice President of Operations
Age: 62
Chief Executive Officer of 180 Medical
President of EMEA
Age: 56
Compensation as of Fiscal Year 2014.

ConvaTec Healthcare B S.a.r.l. Key Developments

Avista Capital And Nordic Capital Reportedly Plans To Sell ConvaTec Healthcare

Avista Capital Holdings, L.P and Nordic Capital are preparing the groundwork for a possible sale or initial public offering (IPO) in 2015 for ConvaTec Healthcare B S.a.r.l., reuters reported citing sources familiar with the matter. Kimberly-Clark Corporation (NYSE:KMB) and 3M Company (NYSE:MMM) are considered likely bidders for ConvaTec. ConvaTec's owners have appointed Morgan Stanley (MS.N) and Goldman Sachs (GS.N) to explore a sale. According to Reuters, ConvaTec, Nordic Capital, 3M, Goldman Sachs and Morgan Stanley declined to comment. Kimberley Clark and Avista Capital did not immediately respond to requests for comment.

ConvaTec Said To Mull Sale and IPO

ConvaTec Healthcare B S.a.r.l. has been approached by investment bankers and potential buyers to discuss a sale that could value the company at $8 billion to $9 billion, people familiar with the matter said. Avista Capital Partners and Nordic Capital won’t start a formal sale-process until later this year at the earliest, and are also considering an initial public offering for ConvaTec, the people said, asking not to be identified discussing private information. While ConvaTec is willing to wait until next year to sell or start a stock offering, the two owners have made it clear to advisers that they would sell at the right price sooner, one of the people said. One potential buyer is 3M Company (NYSE:MMM), one of the people said, though 3M is probably too large a buyer to use ConvaTec to change its tax domicile.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ConvaTec Healthcare B S.a.r.l., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.